- Title: Subtitle
- Outcomes in Refractory Aggressive Diffuse Large B Cell Lymphoma (DLBCL): Results from the International SCHOLAR-1 Study
- Creators
- Michael Crump - Queen's UniversitySattva Neelapu - The University of Texas MD Anderson Cancer CenterUmar Farooq - University of IowaEric Van Den Neste - The Lymphoma Academic Research OrganisationJohn Kuruvilla - Queen's UniversityMohamed Ahmed - The University of Texas MD Anderson Cancer CenterBrian Link - University of IowaAnnette Hay - Queen's UniversityJames Cerhan - Mayo Clinic in FloridaLiting Zhu - Queen's UniversitySami Boussetta - The Lymphoma Academic Research OrganisationLei Feng - The University of Texas MD Anderson Cancer CenterMatthew Maurer - Department of Health Sciences Research, Mayo Clinic, Rochester, MN, United StatesLynn Navale - KiteJeffrey Wiezorek - KiteWilliam Go - KiteChristian Gisselbrecht - The Lymphoma Academic Research Organisation
- Resource Type
- Abstract
- Publication Details
- Clinical lymphoma, myeloma and leukemia, Vol.16, pp.S101-S101
- Publisher
- Elsevier Inc
- DOI
- 10.1016/j.clml.2016.07.147
- ISSN
- 2152-2650
- eISSN
- 2152-2669
- Language
- English
- Date published
- 09/2016
- Academic Unit
- Hematology, Oncology, and Blood & Marrow Transplantation; Internal Medicine; Epidemiology
- Record Identifier
- 9984362749302771
Abstract
Outcomes in Refractory Aggressive Diffuse Large B Cell Lymphoma (DLBCL): Results from the International SCHOLAR-1 Study
Clinical lymphoma, myeloma and leukemia, Vol.16, pp.S101-S101
09/2016
DOI: 10.1016/j.clml.2016.07.147
Details
Metrics
5 Record Views